{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:24:36Z","timestamp":1769387076797,"version":"3.49.0"},"reference-count":169,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.semarthrit.2010.05.008","type":"journal-article","created":{"date-parts":[[2010,7,25]],"date-time":"2010-07-25T05:14:45Z","timestamp":1280034885000},"page":"314-323","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"title":["Systematic Review on the Effectiveness of Immunosuppressants and Biological Therapies in the Treatment of Autoimmune Posterior Uveitis"],"prefix":"10.1016","volume":"40","author":[{"given":"Esperanza","family":"Pato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santiago","family":"Mu\u00f1oz-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F\u00e9lix","family":"Francisco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel A.","family":"Abad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas","family":"Maese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loreto","family":"Carmona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.semarthrit.2010.05.008_bib1","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00281-008-0109-4","article-title":"Advances in the diagnosis and immunotherapy for ocular inflammatory disease","volume":"30","author":"Yeh","year":"2008","journal-title":"Semin Immunopathol"},{"issue":"9","key":"10.1016\/j.semarthrit.2010.05.008_bib2","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1136\/bjo.80.9.844","article-title":"The possible impact of uveitis in blindness: a literature survey","volume":"80","author":"Suttorp-Schulten","year":"1996","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"10.1016\/j.semarthrit.2010.05.008_bib3","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/art.1780400221","article-title":"Patterns of uveitis as a guide in making rheumatologic and immunologic diagnoses","volume":"40","author":"Banares","year":"1997","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.semarthrit.2010.05.008_bib4","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0002-9394(00)00659-0","article-title":"Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel","volume":"130","author":"Jabs","year":"2000","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.semarthrit.2010.05.008_bib5","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/00055735-200312000-00014","article-title":"Use of immunosuppressive agents in uveitis","volume":"14","author":"Lustig","year":"2003","journal-title":"Curr Opin Ophthalmol"},{"issue":"2","key":"10.1016\/j.semarthrit.2010.05.008_bib6","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/00004397-200604620-00013","article-title":"Immunomodulatory therapy for the treatment of ocular inflammatory disease: evidence-based medicine recommendations for use","volume":"46","author":"Kim","year":"2006","journal-title":"Int Ophthalmol Clin"},{"issue":"5 Part 2","key":"10.1016\/j.semarthrit.2010.05.008_bib7","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0002-9394(14)78239-X","article-title":"Signs and symptoms of uveitis","volume":"47","author":"Hogan","year":"1959","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.semarthrit.2010.05.008_bib8","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of uveitis nomenclature for reporting clinical data","volume":"140","author":"Jabs","year":"2005","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.semarthrit.2010.05.008_bib9","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0161-6420(85)34001-0","article-title":"Standardization of vitreal inflammatory activity in intermediate and posterior uveitis","volume":"92","author":"Nussenblatt","year":"1985","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1016\/j.semarthrit.2010.05.008_bib10","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1111\/j.1464-410X.2009.09068.x","volume":"104","year":"2009","journal-title":"BJU Int"},{"issue":"1","key":"10.1016\/j.semarthrit.2010.05.008_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials"},{"issue":"3 Suppl 4","key":"10.1016\/j.semarthrit.2010.05.008_bib12","first-page":"136","article-title":"Evaluation of conventional therapy versus cyclosporine A in Behcet's syndrome","volume":"20","author":"BenEzra","year":"1988","journal-title":"Transplant Proc"},{"issue":"6","key":"10.1016\/j.semarthrit.2010.05.008_bib13","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0002-9394(14)74795-6","article-title":"Combined use of cyclosporine and ketoconazole in the treatment of endogenous uveitis","volume":"113","author":"de Smet","year":"1992","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.semarthrit.2010.05.008_bib14","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1136\/bjo.74.6.344","article-title":"Cyclosporin in the treatment of severe chronic idiopathic uveitis","volume":"74","author":"de Vries","year":"1990","journal-title":"Br J Ophthalmol"},{"issue":"8647","key":"10.1016\/j.semarthrit.2010.05.008_bib15","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0140-6736(89)92381-7","article-title":"Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behcet's disease","volume":"1","author":"Masuda","year":"1989","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.semarthrit.2010.05.008_bib16","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1001\/archopht.123.5.634","article-title":"Cyclosporine vs tacrolimus therapy for posterior and intermediate uveitis","volume":"123","author":"Murphy","year":"2005","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"10.1016\/j.semarthrit.2010.05.008_bib17","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0002-9394(14)76692-9","article-title":"Randomized, double-masked study of cyclosporine compared to prednisolone in the treatment of endogenous uveitis","volume":"112","author":"Nussenblatt","year":"1991","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.semarthrit.2010.05.008_bib18","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0002-9394(14)71454-0","article-title":"A masked, randomized, dose-response study between cyclosporine A and G in the treatment of sight-threatening uveitis of noninfectious origin","volume":"115","author":"Nussenblatt","year":"1993","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.semarthrit.2010.05.008_bib19","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/S0161-6420(97)30248-6","article-title":"Long-term follow-up of patients with chronic uveitis affecting the posterior pole treated with combination cyclosporine and ketoconazole","volume":"104","author":"Ramadan","year":"1997","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.semarthrit.2010.05.008_bib20","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1136\/bjo.76.4.241","article-title":"Low dose cyclosporin A versus pulsed cyclophosphamide in Behcet's syndrome: a single masked trial","volume":"76","author":"Ozyazgan","year":"1992","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"10.1016\/j.semarthrit.2010.05.008_bib21","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1136\/bjo.84.9.979","article-title":"Early treatment with cyclosporin in serpiginous choroidopathy maintains remission and good visual outcome","volume":"84","author":"Araujo","year":"2000","journal-title":"Br J Ophthalmol"},{"issue":"3 Suppl 4","key":"10.1016\/j.semarthrit.2010.05.008_bib22","first-page":"122","article-title":"Treatment of endogenous uveitis with cyclosporine A","volume":"20","author":"BenEzra","year":"1988","journal-title":"Transplant Proc"},{"issue":"4","key":"10.1016\/j.semarthrit.2010.05.008_bib23","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/rheumatology\/26.4.285","article-title":"Cyclosporin A in the treatment of severe Behcet's uveitis","volume":"26","author":"Binder","year":"1987","journal-title":"Br J Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2010.05.008_bib24","first-page":"111","article-title":"Cyclosporine in Behcet's disease resistant to conventional therapy","volume":"21","author":"Caspers-Velu","year":"1989","journal-title":"Ann Ophthalmol"},{"issue":"Pt 2","key":"10.1016\/j.semarthrit.2010.05.008_bib25","first-page":"146","article-title":"Cyclosporin A in the treatment of posterior uveitis","volume":"104","author":"Graham","year":"1985","journal-title":"Trans Ophthalmol Soc UK"},{"issue":"3 Suppl 4","key":"10.1016\/j.semarthrit.2010.05.008_bib26","first-page":"128","article-title":"Cyclosporine in the treatment of birdshot retinochoroidopathy","volume":"20","author":"Le Hoang","year":"1988","journal-title":"Transplant Proc"},{"issue":"3","key":"10.1016\/j.semarthrit.2010.05.008_bib27","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1023\/A:1021227019915","article-title":"Long-term therapy with low dose cyclosporin A in ocular Behcet's disease","volume":"105","author":"Ozdal","year":"2002","journal-title":"Doc Ophthalmol"},{"issue":"2","key":"10.1016\/j.semarthrit.2010.05.008_bib28","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/BF02249016","article-title":"Cyclosporin in Behcet's disease: results in 16 patients after 24 months of therapy","volume":"13","author":"Pacor","year":"1994","journal-title":"Clin Rheumatol"},{"issue":"3 Suppl 4","key":"10.1016\/j.semarthrit.2010.05.008_bib29","first-page":"131","article-title":"Therapy for human autoimmune uveitis with low-dose cyclosporine plus bromocriptine","volume":"20","author":"Palestine","year":"1988","journal-title":"Transplant Proc"},{"issue":"3","key":"10.1016\/j.semarthrit.2010.05.008_bib30","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1089\/jop.1994.10.553","article-title":"Low dose cyclosporin-A therapy in Behcet's disease","volume":"10","author":"Sajjadi","year":"1994","journal-title":"J Ocul Pharmacol"},{"issue":"5-6","key":"10.1016\/j.semarthrit.2010.05.008_bib31","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/BF00163565","article-title":"Cyclosporine-A in the treatment of serpiginous choroiditis","volume":"14","author":"Secchi","year":"1990","journal-title":"Int Ophthalmol"},{"issue":"4","key":"10.1016\/j.semarthrit.2010.05.008_bib32","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000310206","article-title":"Open noncontrolled multicenter long-term trial with ciclosporin in endogenous non-infectious uveitis","volume":"202","author":"Secchi","year":"1991","journal-title":"Ophthalmologica"},{"issue":"1","key":"10.1016\/j.semarthrit.2010.05.008_bib33","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1034\/j.1600-0420.1998.760118.x","article-title":"Cyclosporin-A therapy in severe uveitis of Behcet's disease","volume":"76","author":"Sullu","year":"1998","journal-title":"Acta Ophthalmol Scand"},{"issue":"Pt 3","key":"10.1016\/j.semarthrit.2010.05.008_bib34","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/eye.1989.39","article-title":"Low dose cyclosporin A therapy in chronic posterior uveitis","volume":"3","author":"Towler","year":"1989","journal-title":"Eye"},{"issue":"3","key":"10.1016\/j.semarthrit.2010.05.008_bib35","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/eye.1990.68","article-title":"Combination low dose cyclosporin a and steroid therapy in chronic intraocular inflammation","volume":"4","author":"Towler","year":"1990","journal-title":"Eye"},{"issue":"Suppl A","key":"10.1016\/j.semarthrit.2010.05.008_bib36","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0896-8411(92)90041-N","article-title":"Low-dose cyclosporin therapy of ocular inflammation: preliminary report of a long-term follow-up study","volume":"5","author":"Towler","year":"1992","journal-title":"J Autoimmun"},{"issue":"6","key":"10.1016\/j.semarthrit.2010.05.008_bib37","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/09273940600976938","article-title":"Triple agent immunosuppressive therapy in Vogt-Koyanagi-Harada syndrome","volume":"14","author":"Agarwal","year":"2006","journal-title":"Ocul Immunol Inflamm"},{"issue":"5","key":"10.1016\/j.semarthrit.2010.05.008_bib38","first-page":"321","article-title":"The efficacy of cyclosporin-a in the treatment of Behcet's disease","volume":"25","author":"Atmaca","year":"1994","journal-title":"Ophthalmic Surg"},{"issue":"11","key":"10.1016\/j.semarthrit.2010.05.008_bib39","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1001\/archopht.116.11.1456","article-title":"Immunosuppressive treatment of choroidal neovascularization associated with endogenous posterior uveitis","volume":"116","author":"Dees","year":"1998","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"10.1016\/j.semarthrit.2010.05.008_bib40","first-page":"301","article-title":"Ocular sarcoidosis","volume":"77","author":"Dios Castro","year":"2002","journal-title":"Arch Soc Esp Oftalmol"},{"issue":"Pt 5","key":"10.1016\/j.semarthrit.2010.05.008_bib41","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/eye.1992.95","article-title":"Sympathetic ophthalmia: visual results with modern immunosuppressive therapy","volume":"6","author":"Hakin","year":"1992","journal-title":"Eye"},{"issue":"4","key":"10.1016\/j.semarthrit.2010.05.008_bib42","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1159\/000310490","article-title":"Visual prognosis in patients with Behcet's disease receiving colchicine, systemic corticosteroid or cyclosporin","volume":"208","author":"Hayasaka","year":"1994","journal-title":"Ophthalmologica"},{"issue":"7","key":"10.1016\/j.semarthrit.2010.05.008_bib43","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1136\/bjo.82.7.737","article-title":"Cyclosporin A therapy in refractory non-infectious childhood uveitis","volume":"82","author":"Kilmartin","year":"1998","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"10.1016\/j.semarthrit.2010.05.008_bib44","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.ophtha.2004.12.036","article-title":"Long-term follow-up of patients with birdshot retinochoroidopathy treated with corticosteroid-sparing systemic immunomodulatory therapy","volume":"112","author":"Kiss","year":"2005","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.semarthrit.2010.05.008_bib45","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1442-9071.2005.00904.x","article-title":"Clinical outcome of chronic immunosuppression in patients with non-infectious uveitis","volume":"33","author":"Menezo","year":"2005","journal-title":"Clin Exp Ophthalmol"},{"issue":"2","key":"10.1016\/j.semarthrit.2010.05.008_bib46","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0161-6420(01)00901-0","article-title":"Multifocal choroiditis and panuveitis: immunomodulatory therapy","volume":"109","author":"Michel","year":"2002","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.semarthrit.2010.05.008_bib47","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1136\/bjo.71.5.387","article-title":"Short term cyclosporin A treatment of Behcet's disease","volume":"71","author":"Muftuoglu","year":"1987","journal-title":"Br J Ophthalmol"},{"issue":"2(8344","key":"10.1016\/j.semarthrit.2010.05.008_bib48","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0140-6736(83)90230-1","article-title":"Treatment of intraocular inflammatory disease with cyclosporin A","volume":"30","author":"Nussenblatt","year":"1983","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.semarthrit.2010.05.008_bib49","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0002-9394(14)77814-6","article-title":"Cyclosporin A therapy in the treatment of intraocular inflammatory disease resistant to systemic corticosteroids and cytotoxic agents","volume":"96","author":"Nussenblatt","year":"1983","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.semarthrit.2010.05.008_bib50","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/09273940500536766","article-title":"Immunomodulatory therapy for Vogt-Koyanagi-Harada patients as first-line therapy","volume":"14","author":"Paredes","year":"2006","journal-title":"Ocul Immunol Inflamm"},{"issue":"4","key":"10.1016\/j.semarthrit.2010.05.008_bib51","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1006\/jaut.1993.1039","article-title":"Combined cyclosporin A-steroid-MTX treatment in endogenous non-infectious uveitis","volume":"6","author":"Pascalis","year":"1993","journal-title":"J Autoimmun"},{"issue":"5","key":"10.1016\/j.semarthrit.2010.05.008_bib52","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S0161-6420(13)31254-8","article-title":"Low-dose cyclosporine therapy in the treatment of birdshot retinochoroidopathy","volume":"101","author":"Vitale","year":"1994","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.semarthrit.2010.05.008_bib53","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0161-6420(96)30683-0","article-title":"Low-dose cyclosporin A therapy in treating chronic, noninfectious uveitis","volume":"103","author":"Vitale","year":"1996","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.semarthrit.2010.05.008_bib54","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1089\/jop.1991.7.221","article-title":"Cyclosporine: a therapy in inflammatory eye disease","volume":"7","author":"Wakefield","year":"1991","journal-title":"J Ocul Pharmacol"},{"issue":"11","key":"10.1016\/j.semarthrit.2010.05.008_bib55","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1016\/S0161-6420(98)91120-4","article-title":"Cyclosporine therapy for severe sight-threatening uveitis in children and adolescents","volume":"105","author":"Walton","year":"1998","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.semarthrit.2010.05.008_bib56","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0002-9394(14)72840-5","article-title":"Combined cyclosporine and corticosteroid therapy for sight-threatening uveitis in Behcet's disease","volume":"118","author":"Whitcup","year":"1994","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.semarthrit.2010.05.008_bib57","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1080\/09273940590951061","article-title":"Outcomes of treatment with immunomodulatory therapy in patients with corticosteroid-resistant juvenile idiopathic arthritis-associated chronic iridocyclitis","volume":"13","author":"Yu","year":"2005","journal-title":"Ocul Immunol Inflamm"},{"issue":"6","key":"10.1016\/j.semarthrit.2010.05.008_bib58","first-page":"3343","article-title":"A multicenter clinical open trial of FK 506 in refractory uveitis, including Behcet's disease","volume":"23","author":"Mochizuki","year":"1991","journal-title":"Transplant Proc"},{"issue":"6","key":"10.1016\/j.semarthrit.2010.05.008_bib59","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0002-9394(14)73645-1","article-title":"A clinical trial of FK506 in refractory uveitis","volume":"115","author":"Mochizuki","year":"1993","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.semarthrit.2010.05.008_bib60","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1177\/112067210701700110","article-title":"Long-term follow-up of tacrolimus treatment in immune posterior uveitis","volume":"17","author":"Figueroa","year":"2007","journal-title":"Eur J Ophthalmol"},{"issue":"6","key":"10.1016\/j.semarthrit.2010.05.008_bib61","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0002-9394(14)72551-6","article-title":"FK506 treatment of noninfectious uveitis","volume":"118","author":"Ishioka","year":"1994","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.semarthrit.2010.05.008_bib62","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0161-6420(99)90156-2","article-title":"Tacrolimus (FK506) in the treatment of posterior uveitis refractory to cyclosporine","volume":"106","author":"Sloper","year":"1999","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.semarthrit.2010.05.008_bib63","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.ophtha.2007.01.026","article-title":"Long-term efficacy and tolerance of tacrolimus for the treatment of uveitis","volume":"114","author":"Hogan","year":"2007","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.semarthrit.2010.05.008_bib64","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1076\/ocii.6.2.101.4051","article-title":"Tacrolimus (FK506) in failed cyclosporin A therapy in endogenous posterior uveitis","volume":"6","author":"Kilmartin","year":"1998","journal-title":"Ocul Immunol Inflam"},{"key":"10.1016\/j.semarthrit.2010.05.008_bib65","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/0-306-48382-3_118","article-title":"High dose methotrexate for ocular lesions of Behcet's disease","volume":"528","author":"Davatchi","year":"2003","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"10.1016\/j.semarthrit.2010.05.008_bib66","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0161-6420(99)90011-8","article-title":"Methotrexate treatment for sarcoid-associated panuveitis","volume":"106","author":"Dev","year":"1999","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.semarthrit.2010.05.008_bib67","first-page":"362","article-title":"Methotrexate is an effective treatment for chronic uveitis associated with juvenile idiopathic arthritis","volume":"32","author":"Foeldvari","year":"2005","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2010.05.008_bib68","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1076\/ocii.11.2.131.15919","article-title":"Methotrexate as a first-line corticosteroid-sparing therapy in a cohort of uveitis and scleritis","volume":"11","author":"Kaplan-Messas","year":"2003","journal-title":"Ocul Immunol Inflamm"},{"issue":"3","key":"10.1016\/j.semarthrit.2010.05.008_bib69","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0002-9394(69)92051-0","article-title":"Treatment of uveitis with methotrexate","volume":"67","author":"Lazar","year":"1969","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"10.1016\/j.semarthrit.2010.05.008_bib70","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1136\/bjo.2004.054239","article-title":"The use of low dose methotrexate in children with chronic anterior and intermediate uveitis","volume":"89","author":"Malik","year":"2005","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"10.1016\/j.semarthrit.2010.05.008_bib71","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0161-6420(01)00576-0","article-title":"Methotrexate therapy for chronic noninfectious uveitis: analysis of a case series of 160 patients","volume":"108","author":"Samson","year":"2001","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.semarthrit.2010.05.008_bib72","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3928\/0191-3913-19990501-09","article-title":"Low-dose methotrexate in the treatment of severe juvenile rheumatoid arthritis and sarcoid iritis","volume":"36","author":"Shetty","year":"1999","journal-title":"J Pediatr Ophthalmol Strabismus"},{"issue":"2","key":"10.1016\/j.semarthrit.2010.05.008_bib73","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/09273940600557001","article-title":"Management of pediatric Vogt-Koyanagi-Harada (VKH)-associated panuveitis","volume":"14","author":"Soheilian","year":"2006","journal-title":"Ocul Immunol Inflamm"},{"issue":"2","key":"10.1016\/j.semarthrit.2010.05.008_bib74","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0022-3476(98)70232-X","article-title":"Methotrexate for resistant chronic uveitis in children with juvenile rheumatoid arthritis","volume":"133","author":"Weiss","year":"1998","journal-title":"J Pediatr"},{"issue":"5","key":"10.1016\/j.semarthrit.2010.05.008_bib75","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1136\/bjo.53.5.327","article-title":"Azathioprine in active chronic iridocyclitis","volume":"53","author":"Mathews","year":"1969","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.semarthrit.2010.05.008_bib76","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1056\/NEJM199002013220501","article-title":"A controlled trial of azathioprine in Behcet's syndrome","volume":"322","author":"Yazici","year":"1990","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.semarthrit.2010.05.008_bib77","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1001\/archopht.1978.03910050115002","article-title":"Immunosuppressive therapy for severe chronic uveitis","volume":"96","author":"Andrasch","year":"1978","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.semarthrit.2010.05.008_bib78","first-page":"314","article-title":"Behcet's disease and immunosuppressive treatment","volume":"16","author":"Bietti","year":"1976","journal-title":"Our personal experience Mod Probl Ophthalmol"},{"issue":"6","key":"10.1016\/j.semarthrit.2010.05.008_bib79","first-page":"702","article-title":"Role of Azathioprine in steroid resistant non infectious ocular inflammatory diseases","volume":"135","author":"Cuchacovich","year":"2007","journal-title":"Rev Med Chil"},{"issue":"4","key":"10.1016\/j.semarthrit.2010.05.008_bib80","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/art.1780400425","article-title":"Azathioprine in Behcet's syndrome: effects on long-term prognosis","volume":"40","author":"Hamuryudan","year":"1997","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.semarthrit.2010.05.008_bib81","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3928\/01913913-20070101-03","article-title":"Immunosuppressants used in a steroid-sparing strategy for childhood uveitis","volume":"44","author":"Schatz","year":"2007","journal-title":"J Pediatr Ophthalmol Strabismus"},{"issue":"2","key":"10.1016\/j.semarthrit.2010.05.008_bib82","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1139\/I06-006","article-title":"Combination of azathioprine and corticosteroids in the treatment of serpiginous choroiditis","volume":"41","author":"Vianna","year":"2006","journal-title":"Can J Ophthalmol"},{"issue":"9121","key":"10.1016\/j.semarthrit.2010.05.008_bib83","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0140-6736(05)79515-5","article-title":"Rescue therapy with mycophenolate mofetil in refractory uveitis","volume":"352","author":"Kilmartin","year":"1998","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.semarthrit.2010.05.008_bib84","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0161-6420(99)90078-7","article-title":"Mycophenolate mofetil","volume":"106","author":"Larkin","year":"1999","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.semarthrit.2010.05.008_bib85","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1136\/bjo.2006.094698","article-title":"Mycophenolate mofetil in the treatment of uveitis in children","volume":"91","author":"Doycheva","year":"2007","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"10.1016\/j.semarthrit.2010.05.008_bib86","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1046\/j.1442-9071.2003.00704.x","article-title":"Long-term efficacy of mycophenolate mofetil in the control of severe intraocular inflammation","volume":"31","author":"Lau","year":"2003","journal-title":"Clin Exp Ophthalmol"},{"issue":"7","key":"10.1016\/j.semarthrit.2010.05.008_bib87","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1007\/s00417-005-0066-8","article-title":"Mycophenolate mofetil is a highly effective and safe immunosuppressive agent for the treatment of uveitis : a retrospective analysis of 106 patients","volume":"244","author":"Siepmann","year":"2006","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"8","key":"10.1016\/j.semarthrit.2010.05.008_bib88","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/j.ophtha.2005.02.020","article-title":"Mycophenolate mofetil therapy for inflammatory eye disease","volume":"112","author":"Thorne","year":"2005","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.semarthrit.2010.05.008_bib89","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1136\/bjo.57.9.706","article-title":"Long-lasting remission of Behcet's disease after chlorambucil therapy","volume":"57","author":"Abdalla","year":"1973","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/j.semarthrit.2010.05.008_bib90","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0002-9394(74)90229-3","article-title":"The use of chlorambucil in intractable idiopathic uveitis","volume":"78","author":"Godfrey","year":"1974","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.semarthrit.2010.05.008_bib91","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1136\/bjo.74.6.353","article-title":"High-dose short-term chlorambucil for intractable sympathetic ophthalmia and Behcet's disease","volume":"74","author":"Tessler","year":"1990","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"10.1016\/j.semarthrit.2010.05.008_bib92","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/S0161-6420(02)01097-7","article-title":"Successful treatment of serpiginous choroiditis with alkylating agents","volume":"109","author":"Akpek","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.semarthrit.2010.05.008_bib93","first-page":"264","article-title":"Behcet's syndrome: treatment with chlorambucil","volume":"82","author":"Elliott","year":"1984","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"2","key":"10.1016\/j.semarthrit.2010.05.008_bib94","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1136\/bjo.73.2.140","article-title":"Twenty cases of sympathetic ophthalmia","volume":"73","author":"Jennings","year":"1989","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.semarthrit.2010.05.008_bib95","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0161-6420(01)00864-8","article-title":"Efficacy and safety of chlorambucil in intractable noninfectious uveitis: the Massachusetts Eye and Ear Infirmary experience","volume":"109","author":"Miserocchi","year":"2002","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.semarthrit.2010.05.008_bib96","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1076\/ocii.9.4.219.3957","article-title":"Short-term chlorambucil for refractory uveitis in Behcet's disease","volume":"9","author":"Mudun","year":"2001","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"10.1016\/j.semarthrit.2010.05.008_bib97","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0002-9343(84)90753-8","article-title":"Chlorambucil in the treatment of uveitis and meningoencephalitis of Behcet's disease","volume":"76","author":"O'Duffy","year":"1984","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.semarthrit.2010.05.008_bib98","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1136\/bjo.60.1.55","article-title":"Treatment of Behcet's disease with chlorambucil","volume":"60","author":"Tricoulis","year":"1976","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.semarthrit.2010.05.008_bib99","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.ophtha.2003.08.034","article-title":"Pulse IV cyclophosphamide in ocular inflammatory disease: efficacy and short-term safety","volume":"111","author":"Durrani","year":"2004","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.semarthrit.2010.05.008_bib100","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1001\/archopht.123.7.903","article-title":"A prospective trial of infliximab therapy for refractory uveitis: preliminary safety and efficacy outcomes","volume":"123","author":"Suhler","year":"2005","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"10.1016\/j.semarthrit.2010.05.008_bib101","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10792-006-9006-9","article-title":"Long-term safety and efficacy of infliximab therapy in refractory uveitis due to Behcet's disease","volume":"26","author":"Abu El-Asrar","year":"2005","journal-title":"Int Ophthalmol"},{"issue":"3","key":"10.1016\/j.semarthrit.2010.05.008_bib102","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s10384-006-0425-y","article-title":"Infliximab treatment for ocular and extraocular manifestations of Behcet's disease","volume":"51","author":"Accorinti","year":"2007","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.semarthrit.2010.05.008_bib103","unstructured":"Arayssi T, Hamra R, Homeidan F, Uthman I, Awwad ST, Mroue K, et al. The efficacy of a single dose of infliximab in the treatment of Behcet's disease uveitis. Clin Exp Rheumatol 427;23(3):427."},{"issue":"8","key":"10.1016\/j.semarthrit.2010.05.008_bib104","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/sj.eye.6701689","article-title":"Long-term treatment of refractory posterior uveitis with anti-TNFalpha (infliximab)","volume":"19","author":"Benitez-del-Castillo","year":"2005","journal-title":"Eye"},{"issue":"1","key":"10.1016\/j.semarthrit.2010.05.008_bib105","first-page":"34","article-title":"Medium-long term treatment with infliximab and methotrexate in posterior and\/or chronic uveitis refractory to conventional treatment","volume":"126","author":"Cobo-Ibanez","year":"2006","journal-title":"Med Clin (Barc)"},{"issue":"5","key":"10.1016\/j.semarthrit.2010.05.008_bib106","first-page":"1146","article-title":"Tumor necrosis factor-alpha blocker in treatment of juvenile idiopathic arthritis-associated uveitis refractory to second-line agents: results of a multinational survey","volume":"34","author":"Foeldvari","year":"2007","journal-title":"J Rheumatol"},{"issue":"7","key":"10.1016\/j.semarthrit.2010.05.008_bib107","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/S0161-6420(03)00406-8","article-title":"Infliximab in the treatment of refractory posterior uveitis","volume":"110","author":"Joseph","year":"2003","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.semarthrit.2010.05.008_bib108","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1136\/bjo.2003.037192","article-title":"Anti-TNF-alpha therapy for sight threatening uveitis","volume":"89","author":"Lindstedt","year":"2005","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.semarthrit.2010.05.008_bib109","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.ajo.2004.04.066","article-title":"Infliximab for chronic cystoid macular edema associated with uveitis","volume":"138","author":"Markomichelakis","year":"2004","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"10.1016\/j.semarthrit.2010.05.008_bib110","first-page":"875","article-title":"Effectiveness of infliximab in patients with Behcet syndrome and severe uveoretinitis","volume":"134","author":"Merino","year":"2006","journal-title":"Rev Med Chil"},{"issue":"2","key":"10.1016\/j.semarthrit.2010.05.008_bib111","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/01.iio.0000155901.41938.3c","article-title":"Anti-tumor necrosis factor alpha antibody in the treatment of Behcet's disease","volume":"45","author":"Nakamura","year":"2005","journal-title":"Int Ophthalmol Clin"},{"issue":"7","key":"10.1016\/j.semarthrit.2010.05.008_bib112","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1093\/rheumatology\/kem101","article-title":"Long-term efficacy of infliximab in refractory posterior uveitis of Behcet's disease: a 24-month follow-up study","volume":"46","author":"Niccoli","year":"2007","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.semarthrit.2010.05.008_bib113","doi-asserted-by":"crossref","first-page":"404","DOI":"10.7326\/0003-4819-140-5-200403020-00025","article-title":"Infliximab for recurrent, sight-threatening ocular inflammation in Adamantiades-Behcet disease","volume":"140","author":"Sfikakis","year":"2004","journal-title":"Ann Intern Med"},{"issue":"9278","key":"10.1016\/j.semarthrit.2010.05.008_bib114","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0140-6736(01)05497-6","article-title":"Effect of infliximab on sight-threatening panuveitis in Behcet's disease","volume":"358","author":"Sfikakis","year":"2001","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.semarthrit.2010.05.008_bib115","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1002\/art.21231","article-title":"Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behcet's disease: an open-label trial","volume":"52","author":"Tugal-Tutkun","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.semarthrit.2010.05.008_bib116","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1136\/ard.2004.025882","article-title":"Therapeutic use of infliximab in sight threatening uveitis: retrospective analysis of efficacy, safety, and limiting factors","volume":"64","author":"Bodaghi","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.semarthrit.2010.05.008_bib117","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1016\/j.ophtha.2006.04.038","article-title":"Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation","volume":"113","author":"Galor","year":"2006","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.semarthrit.2010.05.008_bib118","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1136\/bjo.2007.124081","article-title":"Biological response modifier therapy for refractory childhood uveitis","volume":"91","author":"Gallagher","year":"2007","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.semarthrit.2010.05.008_bib119","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.ophtha.2006.01.005","article-title":"Favorable response to high-dose infliximab for refractory childhood uveitis","volume":"113","author":"Kahn","year":"2006","journal-title":"Ophthalmology"},{"issue":"13","key":"10.1016\/j.semarthrit.2010.05.008_bib120","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S0755-4982(05)84079-5","article-title":"Infliximab in the treatment of posterior uveitis in behcet's disease: long term follow up in four patients","volume":"34","author":"Lanthier","year":"2005","journal-title":"Presse Med"},{"issue":"2","key":"10.1016\/j.semarthrit.2010.05.008_bib121","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0161-6420(03)00721-8","article-title":"Tumor necrosis factor alpha blockade with infliximab for refractory uveitis and scleritis","volume":"111","author":"Murphy","year":"2004","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.semarthrit.2010.05.008_bib122","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ophtha.2005.09.037","article-title":"Retrospective case review of pediatric patients with uveitis treated with infliximab","volume":"113","author":"Rajaraman","year":"2006","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.semarthrit.2010.05.008_bib123","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1442-9071.2005.01062.x","article-title":"Infliximab for juvenile idiopathic arthritis-associated uveitis","volume":"33","author":"Richards","year":"2005","journal-title":"Clin Exp Ophthalmol"},{"issue":"8","key":"10.1016\/j.semarthrit.2010.05.008_bib124","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/rheumatology\/kel030","article-title":"Tumour necrosis factor alpha inhibitors in the treatment of childhood uveitis","volume":"45","author":"Saurenmann","year":"2006","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.semarthrit.2010.05.008_bib125","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1136\/ard.2006.065441","article-title":"Use of infliximab in juvenile onset rheumatological disease-associated refractory uveitis: efficacy in joint and ocular disease","volume":"66","author":"Sharma","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.semarthrit.2010.05.008_bib126","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/1529-0131(200106)45:3<252::AID-ART257>3.0.CO;2-5","article-title":"Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease","volume":"45","author":"Smith","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.semarthrit.2010.05.008_bib127","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1001\/archopht.125.7.895","article-title":"Infliximab therapy for the treatment of refractory ocular inflammatory disease","volume":"125","author":"Sobrin","year":"2007","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"10.1016\/j.semarthrit.2010.05.008_bib128","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/ard.2006.058248","article-title":"Infliximab and etanercept in the treatment of chronic uveitis associated with refractory juvenile idiopathic arthritis","volume":"66","author":"Tynjala","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"4 Suppl 34","key":"10.1016\/j.semarthrit.2010.05.008_bib129","first-page":"S14","article-title":"Infliximab in refractory uveitis due to Behcet's disease","volume":"22","author":"Wechsler","year":"2004","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"10.1016\/j.semarthrit.2010.05.008_bib130","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1001\/archopht.121.4.437","article-title":"Efficacy of etanercept in preventing relapse of uveitis controlled by methotrexate","volume":"121","author":"Foster","year":"2003","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"10.1016\/j.semarthrit.2010.05.008_bib131","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/art.20904","article-title":"A randomized, placebo-controlled, double-masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis","volume":"53","author":"Smith","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.semarthrit.2010.05.008_bib132","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1002\/1529-0131(200106)44:6<1411::AID-ART235>3.0.CO;2-O","article-title":"Etanercept therapy in children with treatment-resistant uveitis","volume":"44","author":"Reiff","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.semarthrit.2010.05.008_bib133","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1136\/bjo.2006.103721","article-title":"Adalimumab in the therapy of uveitis in childhood","volume":"91","author":"Biester","year":"2007","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.semarthrit.2010.05.008_bib134","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jpeds.2006.04.058","article-title":"Adalimumab therapy for childhood uveitis","volume":"149","author":"Vazquez-Cobian","year":"2006","journal-title":"J Pediatr"},{"issue":"6","key":"10.1016\/j.semarthrit.2010.05.008_bib135","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/sj.eye.6702352","article-title":"Adalimumab for sight-threatening uveitis in Behcet's disease","volume":"21","author":"Mushtaq","year":"2007","journal-title":"Eye"},{"issue":"2","key":"10.1016\/j.semarthrit.2010.05.008_bib136","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/09273940701299370","article-title":"A double-masked, randomized study to investigate the safety and efficacy of daclizumab to treat the ocular complications related to Behcet's disease","volume":"15","author":"Buggage","year":"2007","journal-title":"Ocul Immunol Inflamm"},{"issue":"13","key":"10.1016\/j.semarthrit.2010.05.008_bib137","doi-asserted-by":"crossref","first-page":"7462","DOI":"10.1073\/pnas.96.13.7462","article-title":"Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: a phase I\/II clinical trial","volume":"96","author":"Nussenblatt","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.semarthrit.2010.05.008_bib138","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.ophtha.2004.12.034","article-title":"Initial evaluation of subcutaneous daclizumab treatments for noninfectious uveitis: a multicenter noncomparative interventional case series","volume":"112","author":"Nussenblatt","year":"2005","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.semarthrit.2010.05.008_bib139","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0896-8411(03)00113-6","article-title":"Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration","volume":"21","author":"Nussenblatt","year":"2003","journal-title":"J Autoimmun"},{"issue":"12","key":"10.1016\/j.semarthrit.2010.05.008_bib140","doi-asserted-by":"crossref","first-page":"593","DOI":"10.4321\/S0365-66912004001200004","article-title":"Recurrent uveitis and therapy with monoclonal antibody (daclizumab)","volume":"79","author":"Hernandez Garfella","year":"2004","journal-title":"Arch Soc Esp Oftalmol"},{"issue":"4","key":"10.1016\/j.semarthrit.2010.05.008_bib141","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0161-6420(02)01932-2","article-title":"Treatment of ocular inflammatory disorders with daclizumab","volume":"110","author":"Papaliodis","year":"2003","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.semarthrit.2010.05.008_bib142","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1097\/01.iae.0000244265.75771.71","article-title":"Interferon alfa-2a: a new treatment option for long lasting refractory cystoid macular edema in uveitis?","volume":"26","author":"Deuter","year":"2006","journal-title":"Retina"},{"issue":"11 Suppl","key":"10.1016\/j.semarthrit.2010.05.008_bib143","first-page":"928","article-title":"Interferon alfa combined with azathioprine for the uveitis of Behcet's disease: an open study","volume":"4","author":"Hamuryudan","year":"2002","journal-title":"Isr Med Assoc J"},{"issue":"6","key":"10.1016\/j.semarthrit.2010.05.008_bib144","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1600-0420.1997.tb00638.x","article-title":"Interferon alpha for ocular Behcet's disease","volume":"75","author":"Pivetti-Pezzi","year":"1997","journal-title":"Acta Ophthalmol Scand"},{"issue":"1","key":"10.1016\/j.semarthrit.2010.05.008_bib145","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ajo.2007.03.050","article-title":"Interferon-alpha as an effective treatment for noninfectious posterior uveitis and panuveitis","volume":"144","author":"Plskova","year":"2007","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.semarthrit.2010.05.008_bib146","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/09273940490518865","article-title":"Interferon alpha-2a treatment for serpiginous choroiditis","volume":"13","author":"Sobaci","year":"2005","journal-title":"Ocul Immunol Inflamm"},{"issue":"10","key":"10.1016\/j.semarthrit.2010.05.008_bib147","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1136\/bjo.2004.061119","article-title":"Interferon as a treatment for uveitis associated with multiple sclerosis","volume":"89","author":"Becker","year":"2005","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/j.semarthrit.2010.05.008_bib148","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1136\/bjo.2006.101550","article-title":"Efficacy of interferon alpha in the treatment of refractory and sight threatening uveitis: a retrospective monocentric study of 45 patients","volume":"91","author":"Bodaghi","year":"2007","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.semarthrit.2010.05.008_bib149","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1136\/ard.62.5.492","article-title":"Effects of interferon alpha treatment on the clinical course of refractory Behcet's disease: an open study","volume":"62","author":"Calguneri","year":"2003","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.semarthrit.2010.05.008_bib150","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1093\/rheumatology\/kem199","article-title":"Efficacy and safety of interferon-alpha in the treatment of corticodependent uveitis of paediatric Behcet's disease","volume":"46","author":"Guillaume-Czitrom","year":"2007","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"10.1016\/j.semarthrit.2010.05.008_bib151","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1007\/s00417-006-0346-y","article-title":"Results of interferon-alfa therapy in patients with Behcet uveitis","volume":"244","author":"Tugal-Tutkun","year":"2006","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"5","key":"10.1016\/j.semarthrit.2010.05.008_bib152","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.semarthrit.2003.09.010","article-title":"The use of interferon alpha in Behcet disease: review of the literature","volume":"33","author":"Kotter","year":"2004","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.semarthrit.2010.05.008_bib153","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1001\/archderm.138.4.467","article-title":"Interferon alfa-2a in the treatment of Behcet disease: a randomized placebo-controlled and double-blind study","volume":"138","author":"Alpsoy","year":"2002","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2010.05.008_bib154","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1136\/bjo.78.1.4","article-title":"Reduction of macular oedema by acetazolamide in patients with chronic iridocyclitis: a randomised prospective crossover study","volume":"78","author":"Farber","year":"1994","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"10.1016\/j.semarthrit.2010.05.008_bib155","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/sj.eye.6700464","article-title":"Evaluation of the effect of acetazolamide on cystoid macular oedema in patients with Behcet's disease","volume":"17","author":"Lashay","year":"2003","journal-title":"Eye"},{"issue":"7","key":"10.1016\/j.semarthrit.2010.05.008_bib156","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0161-6420(96)30567-8","article-title":"A randomized, masked, cross-over trial of acetazolamide for cystoid macular edema in patients with uveitis","volume":"103","author":"Whitcup","year":"1996","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.semarthrit.2010.05.008_bib157","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1001\/archopht.1988.01060140350030","article-title":"Treatment of chronic macular edema with acetazolamide","volume":"106","author":"Cox","year":"1988","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"10.1016\/j.semarthrit.2010.05.008_bib158","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/bjo.82.5.488","article-title":"Treatment of ocular symptoms of Behcet's disease with interferon alpha 2a: a pilot study","volume":"82","author":"Kotter","year":"1998","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.semarthrit.2010.05.008_bib159","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/bjo.87.4.423","article-title":"Human recombinant interferon alfa-2a for the treatment of Behcet's disease with sight threatening posterior or panuveitis","volume":"87","author":"Kotter","year":"2003","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"10.1016\/j.semarthrit.2010.05.008_bib160","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1001\/archopht.122.6.845","article-title":"Neutralizing tumor necrosis factor activity leads to remission in patients with refractory noninfectious posterior uveitis","volume":"122","author":"Murphy","year":"2004","journal-title":"Arch Ophthalmol"},{"issue":"Pt 5","key":"10.1016\/j.semarthrit.2010.05.008_bib161","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/eye.2000.185","article-title":"Deep intramuscular methylprednisolone for the treatment of cystoid macular oedema in uveitis","volume":"14","author":"Tehrani","year":"2000","journal-title":"Eye"},{"issue":"3-4","key":"10.1016\/j.semarthrit.2010.05.008_bib162","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1023\/A:1002469503835","article-title":"Treatment of uveitic macular edema with acetazolamide","volume":"97","author":"Zierhut","year":"1999","journal-title":"Doc Ophthalmol"},{"issue":"2","key":"10.1016\/j.semarthrit.2010.05.008_bib163","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/00006982-200502000-00011","article-title":"Long-term effect of acetazolamide treatment of patients with uveitic chronic cystoid macular edema is limited by persisting inflammation","volume":"25","author":"Schilling","year":"2005","journal-title":"Retina"},{"key":"10.1016\/j.semarthrit.2010.05.008_bib164","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1001\/archopht.1986.01050180081035","article-title":"Intravenous pulse methylprednisolone therapy in severe inflammatory eye disease","volume":"104","author":"Wakefield","year":"1986","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"10.1016\/j.semarthrit.2010.05.008_bib165","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ophtha.2009.08.010","article-title":"Cyclosporine for ocular inflammatory diseases","volume":"117","author":"Kacmaz","year":"2010","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1016\/j.semarthrit.2010.05.008_bib166","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/j.ophtha.2009.04.020","article-title":"Methotrexate for ocular inflammatory diseases","volume":"116","author":"Gangaputra","year":"2009","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.semarthrit.2010.05.008_bib167","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ajo.2009.05.008","article-title":"Azathioprine for ocular inflammatory diseases","volume":"148","author":"Pasadhika","year":"2009","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.semarthrit.2010.05.008_bib168","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ajo.2009.09.026","article-title":"Mycophenolate mofetil for ocular inflammation","volume":"149","author":"Daniel","year":"2010","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.semarthrit.2010.05.008_bib169","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ophtha.2009.06.060","article-title":"Cyclophosphamide for ocular inflammatory diseases","volume":"117","author":"Pujari","year":"2010","journal-title":"Ophthalmology"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017210000843?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017210000843?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T16:53:41Z","timestamp":1758732821000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017210000843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":169,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S0049017210000843"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2010.05.008","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systematic Review on the Effectiveness of Immunosuppressants and Biological Therapies in the Treatment of Autoimmune Posterior Uveitis","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2010.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}